Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sugentech Inc (253840) Fair Value & Analysis

Healthcare · KR · Market cap 73.8B KRW

Price4,070 KRW
Fair Value2,223 KRW
Upside-45.4%
Quality95/100
Evidence: Low Range 1,467 KRW – 2,779 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Sugentech Inc (253840) currently trades at 4,070 KRW, while our model-based Fair Value estimate is 2,223 KRW — implying the stock looks roughly 45.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Sugentech Inc (253840) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 2,223 KRW versus a price of 4,070 KRW — about −45% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 253840?
Our 21-model fair value for Sugentech Inc is 2,223 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 4,070 KRW.
What is the quality score of 253840?
Sugentech Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.